CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
Salt Lake City, Utah, United States and 28 other locations
to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...
Phase 2
Salt Lake City, Utah, United States and 68 other locations
This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...
Phase 1, Phase 2
West Valley City, Utah, United States of America and 37 other locations
The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.
Phase 1
West Valley City, Utah, United States of America and 26 other locations
The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor...
Phase 1
Salt Lake City, Utah, United States and 7 other locations
The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors...
Phase 1
West Valley City, Utah, United States of America and 24 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1
Salt Lake City, Utah, United States and 123 other locations
A Study of XMT-1660 in Solid Tumors...
Phase 1
Salt Lake City, Utah, United States and 22 other locations
The purpose of this study is to measure the safety and efficacy of LY4175408 in participants with selected advanced cancer. In addition, thi...
Phase 1
West Valley City, Utah, United States of America and 23 other locations
This is a Phase 1/2, open-label, first-in-human (FIH) study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (P...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 22 other locations
Clinical trials
Research sites
Resources
Legal